Articles From: AstraZeneca Forecasts Annual Revenue of $45 Billion by 2023 -- Update to Asure Software Launches Portal for Channel Partners


2014/11/18
By Alex MacDonald LONDON--U.K.-listed pharmaceutical company AstraZeneca PLC on Tuesday said its pipeline of drugs is expected to drive strong and consistent revenue growth, delivering annual revenues in excess of $45 billion by 2023.
Sign-up for AstraZeneca Forecasts Annual Revenue of $45 Billion by 2023 -- Update investment picks
2014/12/9
By Tapan Panchal LONDON--AstraZeneca PLC (AZN.LN) said Tuesday that the European Commission has granted it marketing authorization for the constipation drug Moventig.
Sign-up for AstraZeneca Gets European Union Approval For Moventig Drug investment picks
2014/10/15
Recognizing that each person with type 2 diabetes is unique, AstraZeneca today announced the launch of Fit2Me , a free diet and lifestyle support program that allows people with this complex disease to create a diabetes care plan that is custom fit to their likes and dislikes.
Sign-up for AstraZeneca Launches Fit2Me™, a Free Customized Diet and Lifestyle Support Program for People with Type 2 Diabetes investment picks
2014/12/2
By Alex MacDonald LONDON--U.K.-listed drug maker AstraZeneca PLC (AZN) said Tuesday that the U.S. Food and Drug Administration has accepted the filing of a new application for a lung cancer drug called IRESSA.
Sign-up for AstraZeneca New Drug Application For IRESSA Accepted By US FDA investment picks
AstraZeneca (NYSE: AZN) today presented top-line results of two pivotal Phase III trials investigating the potential of lesinurad, a selective uric acid re-absorption inhibitor (SURI), when used in combination with xanthine oxidase (XO) inhibitor allopurinol.
Sign-up for AstraZeneca Presents Data from Phase III Studies of Lesinurad in Combination with Allopurinol in Gout Patients at American College of Rheumatology 2014 Annual Meeting investment picks
2014/11/19
By Tapan Panchal LONDON--AstraZeneca PLC (AZN.LN) said Wednesday that it has successfully priced 750 million Euros ($937.13 million) of notes maturing on Nov.
Sign-up for AstraZeneca Prices EUR750 Million Bonds investment picks
2014/11/6
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- Here are some companies whose shares are making notable moves in European trade on Thursday.
Sign-up for AstraZeneca slides; Adidas jumps: Europe's big stock movers investment picks
2014/12/5
LONDON--A U.S. court has found in favor of AstraZeneca PLC (AZN.LN) in a case filed by purchasers claiming that they had been overcharged for the drugmaker's Nexium heartburn medicine.
Sign-up for AstraZeneca Wins Ruling in Nexium Patent Dispute investment picks
2014/11/4
LONDON , SUNNYVALE, Calif.
Sign-up for AstraZeneca, Pharmacyclics And Janssen Partner On Immuno-Oncology Combination Trials With IMBRUVICA® For Hematologic Cancers investment picks
PARK CITY, Utah, Oct.
Sign-up for ASTRO Gaming Brings Award-Winning Headset Lineup to Xbox One(R) From Microsoft investment picks
Astro-Med, Inc. (NASDAQ: ALOT), a leading manufacturer of specialty high-tech printing systems and data acquisition products, announced that it has repurchased 500,000 shares of the Company’s common stock from the Estate of Albert W.
Sign-up for Astro-Med Announces Repurchase of 500,000 Shares of Common Stock investment picks
Astro-Med, Inc. (NASDAQ: ALOT), a leading manufacturer of specialty high-tech printing systems and data acquisition products, today reported net sales of $23.1 million for the three months ended November 1, 2014, an increase of 27.3% from the same period a year earlier.
Sign-up for Astro-Med Reports Strong Results for Third Quarter Fiscal 2015; Board of Directors Declares Regular Cash Dividend investment picks
Astro-Med, Inc. (NASDAQ:ALOT), a leading manufacturer of specialty high-tech printing systems and data acquisition products, will announce its third-quarter fiscal 2015 financial results pre-market on Wednesday, November 26, 2014 and will host a conference call starting at 9:00 a.m. ET.
Sign-up for Astro-Med, Inc. to Announce Third Quarter FY 2015 Financial Results on November 26 investment picks
EAST AURORA, N.Y., Oct.
Sign-up for Astronics Corporation Announces Third Quarter 2014 Financial Results Conference Call and Webcast investment picks
Organic sales increased by $15.6 million, or 17.4%, to $105.3 million; acquisitions added $74.1 million in revenue for the quarter Record quarterly diluted earnings per share were $0.75 vs.
Sign-up for Astronics Corporation Sales Doubled to Record $179.4 Million While Net Income Increased 138% to Record $17.1 Million for Third Quarter 2014 investment picks
EAST AURORA, N.Y., Sept.
Sign-up for Astronics Corporation to Present at the 2014 Western New York Investors Conference investment picks
Astrotech Corporation (NASDAQ: ASTC), a premier developer of innovative chemical detection technologies for use in the research, security, industrial, process flow and healthcare markets, today announced financial results for its first quarter ended September 30, 2014.
Sign-up for Astrotech Reports First Quarter 2015 Financial Results investment picks
Astrotech Corporation (NASDAQ: ASTC), a leading provider of commercial aerospace services and products and a manufacturer of next generation chemical detection instrumentation, today announced financial results for its fourth quarter and fiscal year ended June 30, 2014.
Sign-up for Astrotech Reports Fourth Quarter and Fiscal Year 2014 Financial Results investment picks
1 st Detect Corporation, a subsidiary of Astrotech Corporation (Nasdaq:ASTC), announced today that the MMS-1000 mass spectrometer has met the regulatory requirements for CE certification.
Sign-up for Astrotech’s 1st Detect Announces European CE Certification for MMS-1000™ investment picks
1 st Detect Corporation, a subsidiary of Astrotech Corporation (Nasdaq:ASTC), announced today that its RoHS compliant OEM-1000PI mass spectrometer has been certified by Underwriter Laboratories as a recognized component meeting IEC 61010-1:2010 (3 rd Edition) standards.
Sign-up for Astrotech’s 1st Detect Announces OEM-1000PI Awarded RoHS Compliance Certification investment picks
2014/10/22
MEXICO D.F., Oct.
Sign-up for ASUR 3Q14 Passenger Traffic Up 8.94% YOY investment picks
2014/12/3
MEXICO CITY , Dec.
Sign-up for ASUR Announces Total Passenger Traffic for November 2014 Up 15.4 % Year over Year investment picks
2014/11/5
MEXICO CITY , Nov.
Sign-up for ASUR Announces Total Passenger Traffic for October 2014 Up 15.8% Year over Year investment picks
2014/10/3
MEXICO CITY , Oct.
Sign-up for ASUR Announces Total Passenger Traffic for September 2014 Up 10.5% Year over Year investment picks
AUSTIN, Texas, Nov.
Sign-up for Asure Software Announces 2014 Third Quarter Earnings Conference Call Details investment picks
Asure Software (Nasdaq:ASUR), a leading provider of workplace management solutions, has upgraded the platform for its AsureForce workforce management solution to incorporate several client-requested functionality enhancements and additions, and optimized the platform’s speed to run 30 percent faster.
Sign-up for Asure Software Announces AsureForce and Workforce Management Platform Upgrades and Optimization investment picks
In thousands, except per share data Q3 2014 Q3 2013 % Change YTD Q3 2014 YTD Q3 2013 % Change Revenue $7,030 $6,470 Up 9% $20,105 $18,742 Up 7% Gross margin $5,435 $4,928 Up 10% $15,579 $13,941 Up 12% Net income (loss) $161 $109 Up 48% ($354) ($1,560) Up 77% EBITDA, excluding one-times* $1,382 $1,462 Down 6% $3,701 $3,340 Up 11% Diluted net income (loss) per share, excluding one-times* $0.04 $0.04   $0.05 ($0.16)   AUSTIN, Texas, Nov.
Sign-up for Asure Software Continues Improvements in Revenue Growth and Profitability With Solid Financial Results for 2014 Third Quarter investment picks
Asure Software (Nasdaq:ASUR), a leading provider of workplace management software solutions, today announced that it helped Scottish Water, one of the UK’s largest water services providers, to implement an agile working program that enabled the client to save £5 million in construction and operating costs in its new office with a 25 percent reduction in the number of workspaces by using Asure’s Workspace Manager solution to support a hot desking and resource sharing system.
Sign-up for Asure Software Helps Scottish Water Implement Agile Worker Program That Saved £5 Million in Construction and Operating Costs in Its New Building investment picks
Asure Software (Nasdaq:ASUR), a leading provider of workplace management software solutions, today announced it has launched the AsureSpace channel partner portal.
Sign-up for Asure Software Launches Portal for Channel Partners investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: AstraZeneca Forecasts Annual Revenue of $45 Billion by 2023 -- Update to Asure Software Launches Portal for Channel Partners
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent